ORGANISATIONAL STUDY AT ASTRAZENECA

By:

Ms.Shilpa Merlin Reg No: 10P35F1059

Under The Guidance Of :-Prof. Sharada Devi

INDUSTRY PROFILE

India's US$ 9.4 billion pharmaceutical industry is growing at the rate of 14 percent per year. reached a market size of US$ 11.6 billion in 2010. Indian Pharmaceutical Industry is strong because -Technologically strong - Totally self-reliant -Low costs of production - Low R&D costs - Innovative scientific manpower - Strength of national laboratories New Trends: Clinical research Contract research

COMPANY PROFILE

VISION & MISSION

VISION:
Focused- be selective about those areas of the industry in which we choose to compete. Integrated - span the full value chain of discovery, development and commercialisation, while remaining open to working with partners and outsourcing to capture operational efficiencies. Innovation driven- technology base will continue to deliver innovative products that will benefit patients and for which payers will pay. Global- believe we have the ability to meet healthcare needs in both established and emerging markets efficiently and effectively.

MISSION:
To make a meaningful difference to the worlds health, we work closely with governments and regulators, those who pay for healthcare, our partners in industry and academia, and doctors.

COMPETITORS
Rank 1 2 3 4 5 6 7
Pfizer GlaxoSmithKline Novartis Sanofi-Aventis AstraZeneca HoffmannLa Roche Johnson & Johnson Merck & Co. Abbott Eli Lilly and Company Amgen Wyeth Teva Bayer Takeda

Company

Sales ($M) 43,363 36,506 36,506 35,642 32,516 30,336 29,425

Based/Headquartered in
US United Kingdom Switzerland France United Kingdom Switzerland US US US US US US Israel Germany Japan

8
9 10 11 12 13 14 15

26,191
19,466 19,140 15,794 15,682 15,274 15,660 13,819

AWARDS & ACHEIVEMENTS

2011 Top 50 Companies, National Association of Female Executives, 2011 2010 CEO Cancer Gold Standard Reaccreditation, CEO Roundtable on Cancer, 2010 2009 100 Best Companies for Working Mothers, Working Mother Magazine, 2009 Best Employer for Healthy Lifestyles, National Business Group on Health, 2009 Employer Support Freedom Award, US Department of Defense, 2009 50 Best Companies, Conceive Magazine, 2009 Best Places to Work in Industry, The Scientist, 2009 Top 50 Companies for Diverse Managers, Diversity MBA Magazine, 2009

PRODUCT PROFILE

Cardiovascular Respiratory

: : : : :

Betaloc, Seloken XL, Imdur, Ramace & Plendil Rhinocort, Mits Linctus, Bricarex & Bricanyl Zoladex & Arimidex, Nolvadex, Iressa & Casodex Meronem & Vancocin CP Entocort, Nexium & Vimovo

Oncology Infection

Gastrointestinal

Neuroscience

Mysoline, Zomig & Vivalan

ORGANISATIONAL STRUCTURE

CHAIRMAN

CEO / MD

Vice President Business Director/ National Sales Director Associate Directors Regional Business Managers (RBM) Area Business Manager (ABM) Sales Development Manager (SDM) Territory Business Manager (TBM)

DEPARTMENTAL DETAILS
Research & Development:- Started on 21 March 2007 in Bangalore - 110 highly qualified scientific staffs - Focus in research on Tuberculosis & Malaria - Process chemistry labs, Analytical labs, Process Safety & Engineering labs, Warehouses & Large Scale Lab

Sales & Marketing:AstraZeneca markets products to: Doctors Healthcare professionals ( Nurses, Pharmacists) Government Global policy on external interactions Direct to consumer Advertising Marketing strategies: Visits, Meeting, Advertising in medical journals, telephone calls, electronic media, internet.

DEPARTMENTAL DETAILS

Human Resource
- 62700 employees in 100 countries - Training & Development : Strategic work force planning, Leadership - FOCUS Survey -Safety, Health & Environment (SHE program) -Outsourced contract- Northgate Arinso -Men: 49% |Women: 51%, Employement type:Fulltime-97% |Part time:3% - Talent Mapping

Finance
Capital Net Profit EPS Net Cash Flow : $ 23,213 Million : $8081 Million : $6.71 : $8340 Million

DEPARTMENTAL DETAILS

Production & Operations

-Fully Automated. -Supply Chain Management. -Lean Philosophy. -Total Productive Maintenance. -Maximum efficiency.

Purchase
General purchase conditions are applicable to all requests, quotations, offers, instructions, purchase orders, order confirmations, agreements and other juridical acts with respect to supply of goods, performance of services, the execution of instructions and the performance of other activities by the supplier for AstraZeneca.

SWOT Analysis
Strengths
-Outstanding portfolio of products. -Global reach. -Creativity & commitment of employees. -Advertising strategies and public activities. -CRM. -Product Design & packing.

Weakness
-Failures of gambles on pipeline medicines. -Drug shortage crisis. -Losing in legal battles. -Dividend Policies.

SWOT Analysis
Opportunities
-Recent Success in china, Latin America & eastern Europe. -Increasing need for innovative drugs for cancer & diabetes. -Tie-up with other companies like Bristol Myres Squibb, Torrent Pharma, jubilant Organosys, Global Alliance. -Investments in biotechnology.

Threats
-Current conditions of Pharma industry . -Drug safety. -Competitions. -Reputations Increasing complaints against marketing procedures. -Issue of patents.

FINDINGS & CONCLUSION

It functions based on the well defined strategies, vision & mission.

Good management employee relationship in the organization.

Qualified and well trained employees in each department and it were found out that the company provide effective training program.

They have a creative and innovative research team.

It is a well reputed organisation and a strong Brand name among the public as well as in market.

Company website is an effective tool to provide information about the product and service.
Heavy growing competition from other companies is effecting marketing.

ANY QUESTIONS?

THANK YOU.!!